BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16534723)

  • 21. Pharmacokinetic comparison of ginsenoside metabolite IH-901 from fermented and non-fermented ginseng in healthy Korean volunteers.
    Jin H; Seo JH; Uhm YK; Jung CY; Lee SK; Yim SV
    J Ethnopharmacol; 2012 Jan; 139(2):664-7. PubMed ID: 22178175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability, pharmacokinetics, and tissue distribution of the oxypregnane steroidal glycoside P57AS3 (P57) from Hoodia gordonii in mouse model.
    Madgula VL; Ashfaq MK; Wang YH; Avula B; Khan IA; Walker LA; Khan SI
    Planta Med; 2010 Oct; 76(14):1582-6. PubMed ID: 20414860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ingested delphinidin-3-rutinoside is primarily excreted to urine as the intact form and to bile as the methylated form in rats.
    Matsumoto H; Ichiyanagi T; Iida H; Ito K; Tsuda T; Hirayama M; Konishi T
    J Agric Food Chem; 2006 Jan; 54(2):578-82. PubMed ID: 16417324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of IDN-6556 (3-[2-(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino]-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid): a liver-targeted caspase inhibitor.
    Hoglen NC; Chen LS; Fisher CD; Hirakawa BP; Groessl T; Contreras PC
    J Pharmacol Exp Ther; 2004 May; 309(2):634-40. PubMed ID: 14742742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of TDP223206 following intravenous and oral administration to intact rats and intravenous administration to bile duct-cannulated rats.
    Chen Y; Cheng D; Marugan JJ; Manthey C; Tomczuk B; Huebert N
    Biopharm Drug Dispos; 2008 May; 29(4):219-30. PubMed ID: 18260095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of guanosine in rats following intravenous or intramuscular administration of a 1:1 mixture of guanosine and acriflavine, a potential antitumor agent.
    Shin DH; Choi KS; Cho BS; Song S; Moon DC; Hong JT; Lee CK; Chung YB
    Arch Pharm Res; 2008 Oct; 31(10):1347-53. PubMed ID: 18958427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the pharmacokinetics of dioscin in rat.
    Li K; Tang Y; Fawcett JP; Gu J; Zhong D
    Steroids; 2005 Jul; 70(8):525-30. PubMed ID: 15894036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LC-MS/MS method for determination of hederacolchiside E, a neuroactive saponin from Pulsatilla koreana extract in rat plasma for pharmacokinetic study.
    Yoo HH; Lee SK; Lim SY; Kim Y; Kang MJ; Kim EJ; Park YH; Im GJ; Lee BY; Kim DH
    J Pharm Biomed Anal; 2008 Dec; 48(5):1425-9. PubMed ID: 18947958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application.
    Wu JW; Lin LC; Hung SC; Chi CW; Tsai TH
    J Pharm Biomed Anal; 2007 Nov; 45(4):635-41. PubMed ID: 17692492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.
    Yang SH; Lee MG
    Biopharm Drug Dispos; 2008 Oct; 29(7):414-26. PubMed ID: 18697186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog and in vitro drug metabolism.
    Chen Y; Cheng D; Tio C; Kagan N; Eisennagel S; Dasgupta M; Tomczuk B; Bone R; Huebert N
    Biopharm Drug Dispos; 2008 Apr; 29(3):127-38. PubMed ID: 18186144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailabilty and pharmacokinetics of four active alkaloids of traditional Chinese medicine Yanhuanglian in rats following intravenous and oral administration.
    Li HL; Zhang WD; Zhang C; Liu RH; Wang XW; Wang XL; Zhu JB; Chen CL
    J Pharm Biomed Anal; 2006 Jun; 41(4):1342-6. PubMed ID: 16644173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible mechanism of adaptogenic activity of seabuckthorn (Hippophae rhamnoides) during exposure to cold, hypoxia and restraint (C-H-R) stress induced hypothermia and post stress recovery in rats.
    Saggu S; Kumar R
    Food Chem Toxicol; 2007 Dec; 45(12):2426-33. PubMed ID: 17673345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and tissue distribution of novel traditional Chinese medicine-platinum anticancer agents in rats.
    Wang X; Au-Yeung SC; Ho YP
    J Inorg Biochem; 2007 Jun; 101(6):909-17. PubMed ID: 17428541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of α- and β-amyrin in rat plasma by gas chromatography-mass spectrometry: application to preclinical pharmacokinetic study.
    Ching J; Lin HS; Tan CH; Koh HL
    J Mass Spectrom; 2011 May; 46(5):457-64. PubMed ID: 21500304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses.
    Beránková K; Szkutová M; Balíková M
    Forensic Sci Int; 2007 Aug; 170(2-3):94-9. PubMed ID: 17629428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.